Genmab A/S Files Form 6-K with Updated Articles of Association
Ticker: GNMSF · Form: 6-K · Filed: Nov 19, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Nov 19, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, legal-documents
Related Tickers: GMAB
TL;DR
Genmab filed a 6-K on Nov 19, 2025, with updated Articles of Association. Nothing major, just housekeeping.
AI Summary
Genmab A/S filed a Form 6-K on November 19, 2025, to report updates. This filing includes their Articles of Association as Exhibit 3.1. The company is registered with the SEC under file number 001-38976 and is based in Valby, Denmark.
Why It Matters
This filing provides updated corporate governance documents for Genmab A/S, which can be important for investors to understand the company's structure and operational framework.
Risk Assessment
Risk Level: low — This filing is primarily administrative, providing updated corporate documents without significant financial or operational news.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 001-38976 (company) — SEC File Number
- November 19, 2025 (date) — Filing Date
- Exhibit 3.1 (document) — Articles of Association
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The Form 6-K filed on November 19, 2025, is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, and it includes their Articles of Association as Exhibit 3.1.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on November 19, 2025.
What is the SEC file number for Genmab A/S?
Genmab A/S's SEC file number is 001-38976.
Where is Genmab A/S's principal executive office located?
Genmab A/S's principal executive office is located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
What specific exhibit is included with this 6-K filing?
Exhibit 3.1, which is the Articles of Association, is included with this 6-K filing.
Filing Stats: 211 words · 1 min read · ~1 pages · Grade level 14.2 · Accepted 2025-11-19 12:48:27
Filing Documents
- gmab_20251119xaoax6k.htm (6-K) — 13KB
- gmab_20251119xex3d1.htm (EX-3.1) — 230KB
- 0001434265-25-000098.txt ( ) — 243KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF NOVEMBER 2025 COMMISSION FILE NUMBER 001-38976 Genmab AS (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab AS's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. EXHIBIT INDEX Exhibit Description of Exhibit 3.1 Articles of Association SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB AS BY s Anthony Pagano Name Anthony Pagano Title Executive Vice President Chief Financial Officer DATE NOVEMBER 19, 2025